Singapore: Lilly and Novast Laboratories have commenced the expansion of manufacturing and development facility capaciti...
Singapore: Switzerland based EPIRUS, a wholly-owned subsidiary of Boston-based EPIRUS Biopharmaceuticals, and Ranbaxy La...
Singapore: The US Food and Drug Administration (FDA) has issued guidance to the Active Pharmaceutical ingredient industr...
Singapore: Teva Pharmaceutical has recieved USFDA approval of the generic equivalent to Evista (Raloxifene) Tablets, 60 ...
Mumbai: Sun Pharmaceutical Industries reported a growth of 62 percent in its net sales for the quarter ending June 30, 2...
Singapore: The Foreign Investment Promotion Board (FIPB) has cleared seven out of the ten investment proposals in the ph...
Singapore: The Australian government has imposed a temporary ban on sales of 19 synthetic drugs pursuant to the product ...
Singapore: The global generic pharmaceuticals market is likely to witness strong growth in the next few years owing to t...
Singapore: Bayer plans to acquire 100 percent of the shares of Dihon Pharmaceutical, a privately held pharmaceutical com...
Singapore: Global pharmaceutical company Actavis has clocked net revenue of $8.7 billion in the year 2013, marking an in...
New Delhi: The global business intelligence firm, ResearchandMarket has filed their latest report with their projections...
Singapore: US Court of Appeals for the Federal Circuit (CAFC) has lifted a temporary injunction against the US launch of...
Singapore: India pharmaceutical companies have yet again emerged as the biggest overseas sources of medicines sold in th...
Singapore: Simcere Pharma has agreed to sell its 99.99 percent stake in Jilin Boda Pharma for $65 million. The company f...
Singapore: Actavis has filed an abbreviated new drug application (ANDA) with the US FDA seeking approval to market Bupre...
Singapore: Global pharmaceutical company, Teva Pharmaceutical, is restructuring its management and organizational functi...
Singapore: Bayer pharmaceuticals announced changes in the top management, declaring Mr Dieter Weinand as the president o...
Mumbai: Indian drug giant Lupin Pharma has begun trial run at Mihan that it expects to become fully functional in two ye...
Bangalore: India-based Dr. Reddy's Laboratories has launched its montelukast sodium oral granules, a bioequivalent gene...
Singapore: Daiichi Sankyo's pharmaceuticals subsidiary, Daiichi Sankyo Espha is all set to launch five generic products ...
Bangalore: India-based Aurobindo Pharma has received final approval from the US Food & Drug Administration for Nevir...
Singapore: After reports of Indian drug majors Ranbaxy Laboratories, Aurobindo Pharma, Dr Reddy's Laboratories and Wockh...
Singapore: Mitsubishi Tanabe Pharma announced that the company has submitted an application for the manufacturing and ma...
Bangalore: India's No 2 biotech company, Bangalore-based Biocon has announced a strategic partnership with global generi...
Singapore: Mayne Pharma Group has announced the launch of Doxycycline Hyclate Delayed-Release tablet in the US through t...
Singapore: Medical Charity, Medecins Sans Frontieres (MSF) has condemned the US for mounting pressure on India's new gov...
Singapore: U.S. Food and Drug Administration (FDA) has approved Novo Nordisk's Biologics License Application (BLA) for r...
Singapore: Novartis Pharmaceuticals has reported to settle its litigation with US subsidiary of India based Sun Pharmace...
Singapore: German drugmaker Bayer announced that Dr Marjin Dekkers will step down as the CEO, by the end of 2016. The fi...
Mumbai: Pharma major Lupin's subsidiary, Lupin Pharmaceuticals, has received final approval for its pregabalin capsules,...
Singapore: Tripura has become the first Indian state to announce its implementation of the country's health ministry's d...
Singapore: As a strong reaction to the import ban placed on Ranbaxy Laboratories' third manufacturing unit in India, the...
Singapore: Leading Indian generic drug maker, Ranbaxy Laboratories, along with its owners, Japan's second largest pharma...
Singapore: Soon after reports of Ranbaxy's Mohali manufacturing plant being issued a Form 483 by the US US FDA broke out...
Singapore: The US subsidiary of Japanese drug major Astellas Pharma has entered into a distribution agreement with Tecno...
Mumbai: Dr. Reddy's Laboratories, India's leading pharmaceutical company, recently launched Montelukast Sodium Tablets a...
Singapore: The South East Asian pharmaceuticals industry is forecast to witness a boost to $3.9 billion by 2016. The in...
Singapore: The police in China have made it official that four senior Chinese executives of GlaxoSmithKline have been de...
Singapore: Mayne Pharma from Australia has made a second US acquisition by buying privately-held US-based generic drugma...
Singapore: Chinese prosecutors have received more than 600,000 inquiries about bribery records involving companies or in...
Singapore: Even as police in China are investigating claims of bribery against the British drug major for bribing doctor...
Singapore: In a move that is threatening to become a high profile patent infringement suit, global biopharma company UCB...
Singapore: Japan's pharmaceutical industry is the second largest in the world, worth $89 billion in 2011 or 10 percent o...
Singapore: A report by Cutting Edge Information titled, 'Post-patent generic and biosimilar defense: Harnessing competit...
Singapore: The Indian Health Ministry has banned the blockbuster diabetes drug Actos along with suspending sales of pain...
Singapore: The Chinese police have reportedly detained employees of British pharmaceuticals major GlaxoSmithKline (GSK) ...
Dr Yusuf K Hamied, CMD of India's largest pharma company, Cipla, has earned many unflattering epithets for building a co...
India's top drug regulatory body, the Central Drug Standard Control Organization (CDSO) is literally facing the heat, th...
Mumbai: Sun Pharmaceutical Industries received final approval from the US FDA for its abbreviated new drug application (...
Singapore: A new study by GlobalData has revealed that New Zealand's Pharmaceutical Management Agency's (PHARMAC) is emp...
Singapore: In support of its commitment to maximize growth opportunities in China, Eli Lilly has decided to increase its...
Singapore: A new report by investment bank Alpen Capital titled, 'The GCC pharmaceutical Outlook', a number of Gulf Coop...
Singapore: Japan's Meiji Seika Pharma is set to acquire Bangalore-based generic drug maker Medreich for $290 million. Th...
Two separate but equally important developments took place in China this month. One, intensification of investigations i...
Singapore: Mylan signed a new agreement between its subsidiary Mylan Laboratories and Gilead Sciences. According top thi...
Singapore: US-based Actavis reached a settlement agreement with AstraZeneca resolving outstanding patent litigation rela...
Singapore: Pharma industry leaders Pfizer and GlaxoSmithKline have joined hands with global engineering giants Siemens t...
Singapore: Generics are predicted to take over the antiviral drugs market, especially in the case of HIV medication, as ...
Hyderabad: Fujifilm and Dr Reddy's Laboratories have decided to terminate the memorandum of understanding (MoU) to enter...
Hyderabad: Dr Reddy's Laboratories (DRL) launched Zoledronic Acid Injection (4 mg/5 mL), a bioequivalent generic versio...
Singapore: Two weeks after intense investigations into GlaxoSmithKline's (GSK) operations across China, the country's se...
Bangalore: Ranbaxy Pharmaceuticals, a wholly owned subsidiary of Ranbaxy Laboratories, has entered into an in-licensing...
New Delhi: The Indian government will be reviewing the foreign direct investment (FDI) policies for the pharmaceutical i...
Singapore: Days after the Drug Controller General of India (DCGI) approved Cadila Healthcare's new chemical entity, Lipa...
Singapore: Biopharmaceutical companies Gilead Sciences and Teva Pharmaceuticals have decided to settle the ongoing paten...
Singapore: A day after making the allegations against GlaxoSmithKline's senior executives public, China's Public Securit...
Singapore: Shasun pharmaceuticals an Indian pharmaceutical company, aims to focus on formulations manufacturing and mark...
Singapore: Global organization, International Osteoporosis Foundation (IOF), and New Zealand dairy firm, Fonterra have c...
Singapore: Global pharmaceutical firm, Mylan, has launched Telmisartan tablets-20 mg, 40 mg and 80 mg, the generic versi...
Australian drug delivery technology company Imugene has developed Linguet, a drug delivery technology platform, to impro...
Singapore: Global pharmaceutical firm Abbott is planning to sell its developed markets branded generics pharmaceuticals ...
Singapore: The year 2014 is bringing back haunting memories of the way the year gone by had started for India's biggest ...
Singapore: China's State Food and Drug Administration (SFDA) issued an Import Drug License (IDL) for Takeda's type 2 di...
Singapore: Dr. Reddy's Laboratories has launched Donepezil Hydrochloride tablets, 23 mg, a therapeutic equivalent generi...
Singapore: Simplification of the regulatory process will prove to be the key to the growth of the pharma market in Japan...
Texas-headquartered ULURU Inc has expanded its distribution network by entering into a cooperation agreement with Saraya...
Singapore: Actonel 75 mg tablets and Benet 75 mg tablets, a once-monthly formulation of risedronate sodium hydrate (gene...
Singapore: Israel-based Teva Pharmaceutical and US-based Perrigo have launched generic version of cancer drug Temodar (t...
Singapore: Taiwan's TWi Pharmaceuticals has recieved ANDA approval of the generic equivalent to Procardia XL (Nifedipine...
Singapore: Japan-based Takeda Pharmaceutical and Amsterdam-based Norgine has received Japanese Ministry of Health, Labo...
Singapore: About two months after the US Food and Drug Administration (US FDA) issued a Form 483 to Wockhardt for drug q...
Singapore: Horizon, an Irish engineerng consultancy firm, has completed testing of its new tracking system that aims at ...
Singapore: Mylan Pharmaceuticals received final approval from the US FDA for its abbreviated new drug application (ANDA)...
Singapore: Japan's Daiichi Sankyo and Ranbaxy Laboratories have plans to integrate their business operations in Thailand...
Singapore: AstraZeneca and Bristol-Myers Squibb have recieved U.S. Food and Drug Administration (FDA) approval for diabe...
New Delhi: Ranbaxy issued an advisory claiming that all their products in the Indian and global markets are safe and eff...
Singapore: Vietnam has seen a substantial increase in the number of rabies fatalities from 34 deaths in 2003 to 131 deat...
Singapore: Merely a month after Indian drug major, Ranbaxy, pleaded guilty of having misled the USFDA investigations, se...
Singapore: Mundipharma has entered a license agreement with Japan-based Shionogi for the exclusive rights to develop, ma...
Singapore: Britian's leading drug maker, GlaxoSmithKline has filed for US Food and Drug Administration (US FDA) approval...
Singapore: WHO and Global Fund to Fight AIDS, TB and Malaria have stressed on strains of tuberculosis with resistance to...
Singapore: US based Avanir Pharmaceuticals has entered into a settlement agreement with India's Wockhardt to resolve pen...
Singapore: Taiwan-based TWi Pharmaceuticals has received tentative approval for its Abbreviated New Drug Application (AN...
Singapore: The generics unit of Novartis, Sandoz, has launched a late-stage trial with its biosimilar version of Amgen's...
Singapore: US based Par Pharmaceutical has entered into agreements with Watson Pharmaceuticals and Actavis Group to purc...
In a landmark decision, Hyderabad-based NATCO Pharma has been granted compulsory license for Sorafenib Tosylate sold und...
Singapore: Mylan Institutional business has received final approval from the US Food and Drug Administration (FDA) for ...
Singapore: The European Commission (EC) and other leading pharma giants have come together to invest $4.4 billion into p...
Singapore: US Pharmacopeial Convention (USP) is gearing up its efforts to combat fake medicine circulating in the market...
Singapore: Indian pharmaceutical firm, Arvind Remedies has been gearing up to take the US market by storm. The company h...
